Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (181-190 of 276) with videos related to

Pageof 28
Sort By:
Journal of Immunology Research|June 14, 2016
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Claudia Cantoni, Leticia Huergo-Zapico, Monica Parodi, et al.
Oncotarget|May 1, 2017
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Alessandra Dondero, Beatrice Casu, Francesca Bellora, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failureSofiane Mohamed, Marc Bourliere, Souad Benali, et al.
Leukemia & Lymphoma|February 11, 2014
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVadim Ivanov, Diane Coso, Bruno Chetaille, et al.
International Journal of Cancer|February 18, 2011
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinomaJocelyne Jacquemier, François Bertucci, Pascal Finetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2010
B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their functionNacer-Eddine Serriari, Françoise Gondois-Rey, Yves Guillaume, et al.
Blood|October 12, 2012
HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cellsJonathan Florentin, Besma Aouar, Clélia Dental, et al.
Journal of Clinical Immunology|August 24, 2012
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patientsDavid Eric Ouedraogo, Alain Makinson, Nils Kuster, et al.
Journal of Cell Science|March 5, 2004
Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitmentGrégory Bonello, Nicolas Blanchard, Maria C Montoya, et al.
Cancers|April 3, 2021
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic MelanomaFrançoise Gondois-Rey, Magali Paul, Florence Alcaraz, et al.
Pageof 28

Showing results (181-190 of 276) with videos related to

Sort By:
Pageof 28
Journal of Immunology Research|June 14, 2016
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Claudia Cantoni, Leticia Huergo-Zapico, Monica Parodi, et al.
Oncotarget|May 1, 2017
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Alessandra Dondero, Beatrice Casu, Francesca Bellora, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failureSofiane Mohamed, Marc Bourliere, Souad Benali, et al.
Leukemia & Lymphoma|February 11, 2014
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVadim Ivanov, Diane Coso, Bruno Chetaille, et al.
International Journal of Cancer|February 18, 2011
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinomaJocelyne Jacquemier, François Bertucci, Pascal Finetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2010
B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their functionNacer-Eddine Serriari, Françoise Gondois-Rey, Yves Guillaume, et al.
Blood|October 12, 2012
HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cellsJonathan Florentin, Besma Aouar, Clélia Dental, et al.
Journal of Clinical Immunology|August 24, 2012
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patientsDavid Eric Ouedraogo, Alain Makinson, Nils Kuster, et al.
Journal of Cell Science|March 5, 2004
Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitmentGrégory Bonello, Nicolas Blanchard, Maria C Montoya, et al.
Cancers|April 3, 2021
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic MelanomaFrançoise Gondois-Rey, Magali Paul, Florence Alcaraz, et al.
Pageof 28